Stock 9877 JENSCARE SCIENTIFIC CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Jenscare Scientific Co., Ltd.

Equities

9877

CNE100005KC9

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:23 12/06/2024 pm IST 		5-day change 1st Jan Change
3.97 HKD +0.25% Intraday chart for Jenscare Scientific Co., Ltd. +1.02% -82.12%
25/04 Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11% MT
27/03 Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%
MT
Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jenscare Scientific's Mitral Valve Device Completes Enrollment for Confirmatory Clinical Trials
MT
Jenscare Scientific Co., Ltd. Announces Completion of the Enrollment of JensClip for Confirmatory Clinical Trial and One-Month Follow-Up
CI
Jenscare Scientific Secures HKEX Nod for H Share Circulation
MT
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation in Brazil
CI
Jenscare Scientific’s CEO, CFO Boost Stake in Firm
MT
Jenscare Scientific Unit Concludes 1st Clinical Implantation of PFO Occluder System
MT
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation of Omniseal
CI
Jenscare Scientific to Buy Back Shares
MT
Jenscare Scientific Shareholders Approve of Sale of 22.48% Interest in Congenital Heart Disease Device Maker
MT
Jenscare Scientific to Divest 22.5% Stake in Medical Device Maker
MT
Jenscare Releases Results of Confirmatory Trial for Tricuspid Valve Replacement in London Meet
MT
Jenscare Scientific Co., Ltd. Announces One-Year Results of the Confirmatory Clinical Trial of the LuX-Valve Transcatheter Tricuspid Valve Replacement System
CI
Jenscare Scientific Enrolls First Patient for Atrial Appendage Occluder System Trial
MT
Jenscare Presents Results of Tricuspid Valve Replacement System at US Conference
MT
Jenscare Scientific Co., Ltd. Announces Lux-Valve Plus Travel II Results Released At the 2023 TCT in the U.S
CI
Jenscare Shares Surge 16% After China Grants Priority Approval for Aortic Heart Valve System
MT
Jenscare Scientific Co., Ltd. Announces Registration Application of Ken-Valve, the Transcatheter Prosthetic Aortic Heart Valve System Successfully Enters the Priority Approval Process
CI
Jenscare Scientific Applies Valve Replacement System Under Fee-for-Service Scheme in Asia-Pacific; Shares Tumble 9%
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 9877 Stock
  4. News Jenscare Scientific Co., Ltd.